Study of a new skin cream for basal cell carcinoma
Part of Cancer, Skin clinical trials.
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have at least one nodular (lumpy) basal cell carcinoma that has not been treated.
- Your skin lesion is not located in a high-risk area (such as near the eyes, nose, ears, lips, scalp, or on your hands or fingers).
- You are not pregnant, not breastfeeding, and you or your partner must use effective birth control during the study and for 90 days after your last dose.
- You do not have a history of other cancers in the past 5 years (except some skin cancers).
- You are not currently participating in another clinical trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests EscharEx (an investigational treatment) to see if it is safe and works on a single small basal cell skin cancer on the trunk or upper arms. You might qualify if your cancer fits specific size and location rules and you have not had radiation to that spot.
This trial compares two treatments for certain types of skin cancer (basal cell carcinoma) and a very early skin cancer called Bowen's disease. One treatment uses high-intensity focused ultrasound (HIFU) and the other uses freezing (cryotherapy). It aims to find out which works better for lesions on the body, from the neck down to the knees.
This trial tests a new treatment that combines light (photodynamic therapy) and sound (sonodynamic therapy) to treat a common type of skin cancer called nodular basal cell carcinoma. The goal is to see if this combination works better than light alone for small tumors.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
This study is testing a new imaging technology that helps surgeons see if all the cancer cells have been removed during Mohs surgery for basal cell carcinoma. It may help improve accuracy and reduce the need for additional surgeries.
This trial tests a combination drug (L19IL2/TNF) given as injections into skin tumors. It is for people with advanced basal cell carcinoma that has worsened after or cannot tolerate standard treatments.
Hear when a new Nodular Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.